UBS Group’s T-REX 2X Inverse CRCL Daily Target ETF CRCD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.67K Buy
+382
New +$1.79K ﹤0.01% 9311
2026
Q1
Sell
-963
Closed -$33.1K 11728
2025
Q4
$33.1K Buy
+963
New +$29.2K ﹤0.01% 7467

Other funds holding CRCD

UBS Group's CRCD Position: Q2 2026 in Review

UBS Group opened a new position in T-REX 2X Inverse CRCL Daily Target ETF (CRCD) in Q2 2026: 382 shares worth $2.67K. The stake represents ﹤0.01% of the portfolio and ranks #9311 among its holdings. This is a return to the name: UBS Group previously reported a position in CRCD as recently as Q4 2025.

UBS Group first reported a position in CRCD in Q4 2025 and has held it in 2 quarters since. The position peaked at $33.1K in Q4 2025. 12 funds tracked by Wall St. Rank hold CRCD as of Q2 2026.

  • UBS Group held 382 shares of T-REX 2X Inverse CRCL Daily Target ETF worth $2.67K as of Q2 2026.
  • T-REX 2X Inverse CRCL Daily Target ETF was a new UBS Group position in Q2 2026.
  • T-REX 2X Inverse CRCL Daily Target ETF made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #9311 holding.
  • UBS Group first reported a position in T-REX 2X Inverse CRCL Daily Target ETF in Q4 2025 and has held it in 2 quarters since.
  • UBS Group's T-REX 2X Inverse CRCL Daily Target ETF position peaked at $33.1K in Q4 2025.
  • 12 funds tracked by Wall St. Rank held T-REX 2X Inverse CRCL Daily Target ETF as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.